Alder BioPharmaceuticals
Alder is a biopharmaceutical company that focuses on developing novel therapeutic antibodies for the treatment of migraine.
Business Model:
Revenue: $6.5M
Employees: 201-500
Industries / Tags:
Detailed Alder BioPharmaceuticals Information
Alder BioPharmaceuticals was acquired by
Lundbeck.
The acquisition happend on 2019-09-16.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 11804 North Creek Parkway South
City: Bothell
State: WA
Zip: 98011
Country: US
Financial Info
Stage:
post ipo equity
Raised Last:
$170M
Raised Total:$525M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Alder is a biopharmaceutical company that focuses on developing novel therapeutic antibodies for the treatment of migraine.
Contact Phone:
+14252052900
Contact Email:
Alder BioPharmaceuticals went public on 5/8/2014 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
5/8/2014
IPO Valuation:
$407M
Ticker Symbol:
ALDR
IPO Price:
$45.5/share
Amount Raised:
$200M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
